Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-7,200
Closed -$522K 599
2017
Q2
$522K Sell
7,200
-234,400
-97% -$15.8M 0.02% 552
2017
Q1
$15.7M Sell
241,600
-223,800
-48% -$14.1M 0.11% 118
2016
Q4
$29.1M Buy
465,400
+123,700
+36% +$7.55M 0.13% 119
2016
Q3
$21.6M Buy
341,700
+29,900
+10% +$1.94M 0.1% 166
2016
Q2
$19.3M Sell
311,800
-6,500
-2% -$396K 0.09% 186
2016
Q1
$18.2M Buy
318,300
+105,600
+50% +$5.89M 0.09% 194
2015
Q4
$12.6M Sell
212,700
-334,400
-61% -$19.3M 0.06% 267
2015
Q3
$29.8M Buy
547,100
+371,100
+211% +$24.2M 0.12% 139
2015
Q2
$11.8M Sell
176,000
-218,300
-55% -$14.3M 0.05% 309
2015
Q1
$23.1M Buy
394,300
+71,850
+22% +$4.34M 0.1% 170
2014
Q4
$21.1M Buy
322,450
+33,850
+12% +$2.13M 0.08% 195
2014
Q3
$16.7M Buy
288,600
+105,400
+58% +$5.85M 0.07% 229
2014
Q2
$10.3M Buy
183,200
+178,950
+4,211% +$9.39M 0.05% 324
2014
Q1
$218K Sell
4,250
-29,350
-87% -$1.48M ﹤0.01% 2547
2013
Q4
$1.77M Buy
33,600
+17,850
+113% +$877K 0.01% 1452
2013
Q3
$704K Buy
15,750
+200
+1% +$8.87K ﹤0.01% 2194
2013
Q2
$643K Buy
+15,550
New +$680K ﹤0.01% 2300

Other funds holding ABBV

Timber Hill's ABBV Position: Q2 2018 in Review

Timber Hill sold out of AbbVie (ABBV) in Q2 2018, closing a stake of 11,232 shares — an estimated $1.06M sold.

Timber Hill first reported a position in ABBV in Q2 2013 and held it in 9 quarters. The position peaked at $4.51M in Q1 2015. 1,996 funds tracked by Wall St. Rank hold ABBV as of Q2 2018.

  • Timber Hill reported no remaining AbbVie position as of Q2 2018 after selling out during the quarter.
  • Timber Hill sold 11,232 AbbVie shares in Q2 2018, an estimated $1.06M.
  • Timber Hill first reported a position in AbbVie in Q2 2013 and held it in 9 quarters.
  • Timber Hill's AbbVie position peaked at $4.51M in Q1 2015.
  • 1,996 funds tracked by Wall St. Rank held AbbVie as of Q2 2018.

Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.